Company page

Brightgene Bio-medical Technology Co. Ltd. Class A

Brightgene Bio-medical Technology Co. Ltd. Class A, trading under the ticker 688166, operates in the Chinese market with a market capitalization of approximately 1.91 billion USD. The company focuses on the development and commercialization of innovative biopharmaceutical products. Brightgene aims to advance healthcare solutions through its research and technological advancements in the biomedical field.